Overview of bone microstructure, and treatment of bone fragility in chronic kidney disease

Nephrology (Carlton). 2017 Mar;22 Suppl 2:34-35. doi: 10.1111/nep.13024.
No abstract available

MeSH terms

  • Bone Density / drug effects*
  • Bone Density Conservation Agents / adverse effects
  • Bone Density Conservation Agents / therapeutic use*
  • Bone Remodeling / drug effects*
  • Bone and Bones / diagnostic imaging
  • Bone and Bones / drug effects*
  • Bone and Bones / physiopathology
  • Chronic Kidney Disease-Mineral and Bone Disorder / diagnosis
  • Chronic Kidney Disease-Mineral and Bone Disorder / drug therapy*
  • Chronic Kidney Disease-Mineral and Bone Disorder / etiology
  • Chronic Kidney Disease-Mineral and Bone Disorder / physiopathology
  • Fractures, Bone / diagnostic imaging
  • Fractures, Bone / etiology
  • Fractures, Bone / physiopathology
  • Fractures, Bone / prevention & control*
  • Humans
  • Predictive Value of Tests
  • Renal Insufficiency, Chronic / complications
  • Renal Insufficiency, Chronic / diagnosis
  • Renal Insufficiency, Chronic / physiopathology
  • Renal Insufficiency, Chronic / therapy*
  • Risk Factors

Substances

  • Bone Density Conservation Agents